January 26, 2012 — Heart Hospital of Austin opened a heart valve clinic, the first of its kind in the region. The clinic ...
Heart Valve Technology
This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR).
January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology ...
January 17, 2012 – Terumo Americas Holding Inc., a U.S. subsidiary of Japan's Terumo Corp., announced it acquired Onset ...
January 4, 2012 – ECRI, an independent nonprofit that researches the best approaches to improving patient care, listed ...
December 28, 2011 – Edwards Lifesciences announced two-year results of a pivotal clinical study of inoperable patients ...
December 23, 2011 - Philips Healthcare said Medical City Dallas Hospital, Dallas, Texas, is the first hospital in the ...
Each year that I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking ...
Transcatheter aortic valve repair (TAVR) — also commonly referred to as transcatheter aortic valve implantation (TAVI) — ...
Patient History
72-year-old, male patient with previously placed bioprosthetic mitral valve.
Diagnosis
Mitral ...
Each year that I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking for ...
November 15, 2011 — A two-year study of patients in the landmark PARTNER trial confirms the one-year findings and ...
November 15, 2011 – Results of the PARTNER Cohort A QOL study demonstrate that transcatheter aortic valve replacement ...
November 14, 2011 — Edwards Lifesciences Corp. announced data were presented on the quality of life impact and cost ...
November 10, 2011 — The results of an analysis of 149 EVEREST II high surgical risk patients with significant mitral ...
November 10, 2011 — Edwards Lifesciences Corp. announced the U.S. Food and Drug Administration (FDA) conditionally ...